Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.06 Million USD | -52.54% |
| 2022 | 29.62 Million USD | 74.41% |
| 2021 | 16.98 Million USD | 223.64% |
| 2020 | 5.24 Million USD | -70.1% |
| 2019 | 17.55 Million USD | 3.82% |
| 2018 | 16.91 Million USD | 22.54% |
| 2017 | 13.79 Million USD | 40.16% |
| 2016 | 9.84 Million USD | 49.76% |
| 2015 | 6.57 Million USD | 75.07% |
| 2014 | 3.75 Million USD | -45.4% |
| 2013 | 6.87 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.42 Million USD | -18.6% |
| 2024 Q1 | 6.66 Million USD | -14.91% |
| 2023 Q4 | 7.82 Million USD | 293.61% |
| 2023 Q1 | 1.62 Million USD | -80.58% |
| 2023 Q2 | 2.61 Million USD | 61.47% |
| 2023 Q3 | 1.98 Million USD | -24.05% |
| 2023 FY | 14.06 Million USD | -52.54% |
| 2022 Q3 | 5.87 Million USD | -28.85% |
| 2022 Q4 | 8.35 Million USD | 42.17% |
| 2022 FY | 29.62 Million USD | 74.41% |
| 2022 Q1 | 7.14 Million USD | -19.27% |
| 2022 Q2 | 8.25 Million USD | 15.48% |
| 2021 Q4 | 8.85 Million USD | 176.63% |
| 2021 Q3 | 3.2 Million USD | -4.3% |
| 2021 Q2 | 3.34 Million USD | 110.91% |
| 2021 FY | 16.98 Million USD | 223.64% |
| 2021 Q1 | 1.58 Million USD | -50.88% |
| 2020 Q2 | 639.65 Thousand USD | -9.72% |
| 2020 FY | 5.24 Million USD | -70.1% |
| 2020 Q4 | 3.22 Million USD | 380.17% |
| 2020 Q3 | 672.37 Thousand USD | 5.12% |
| 2020 Q1 | 708.5 Thousand USD | -87.02% |
| 2019 Q4 | 5.45 Million USD | 42.0% |
| 2019 FY | 17.55 Million USD | 3.82% |
| 2019 Q2 | 4.93 Million USD | 48.95% |
| 2019 Q3 | 3.84 Million USD | -22.18% |
| 2019 Q1 | 3.31 Million USD | -31.79% |
| 2018 Q4 | 4.86 Million USD | 16.62% |
| 2018 FY | 16.91 Million USD | 22.54% |
| 2018 Q1 | 3.94 Million USD | -8.65% |
| 2018 Q2 | 3.94 Million USD | 0.01% |
| 2018 Q3 | 4.16 Million USD | 5.79% |
| 2017 Q3 | 3.21 Million USD | -5.75% |
| 2017 Q2 | 3.41 Million USD | 19.6% |
| 2017 Q1 | 2.85 Million USD | -14.58% |
| 2017 Q4 | 4.31 Million USD | 34.04% |
| 2017 FY | 13.79 Million USD | 40.16% |
| 2016 Q1 | 1.93 Million USD | -19.63% |
| 2016 Q2 | 2.32 Million USD | 20.04% |
| 2016 Q3 | 2.25 Million USD | -2.98% |
| 2016 FY | 9.84 Million USD | 49.76% |
| 2016 Q4 | 3.34 Million USD | 48.46% |
| 2015 Q3 | 1.41 Million USD | -8.5% |
| 2015 Q1 | 1.2 Million USD | 0.0% |
| 2015 FY | 6.57 Million USD | 75.07% |
| 2015 Q4 | 2.4 Million USD | 69.83% |
| 2015 Q2 | 1.54 Million USD | 28.39% |
| 2014 FY | 3.75 Million USD | -45.4% |
| 2013 FY | 6.87 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -451.373% |
| BrainsWay Ltd. | 23.09 Million USD | 39.11% |
| Cerus Corporation | 86.4 Million USD | 83.727% |
| Envoy Medical, Inc. | -473 Thousand USD | 3072.516% |
| electroCore, Inc. | 13.22 Million USD | -6.306% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -22949.18% |
| IceCure Medical Ltd | 1.3 Million USD | -981.538% |
| Inogen, Inc. | 126.69 Million USD | 88.903% |
| OrthoPediatrics Corp. | 111.25 Million USD | 87.362% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 332.397% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 29802.552% |
| MaxCyte, Inc. | 36.54 Million USD | 61.528% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -2979.841% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -16429.509% |
| Orthofix Medical Inc. | 486.27 Million USD | 97.109% |
| PAVmed Inc | -3.96 Million USD | 454.335% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 356.335% |
| RxSight, Inc. | 53.76 Million USD | 73.849% |
| Sight Sciences, Inc. | 69.17 Million USD | 79.675% |
| SI-BONE, Inc. | 109.42 Million USD | 87.15% |
| TELA Bio, Inc. | 40.11 Million USD | 64.948% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 90.746% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -69.992% |
| Acutus Medical, Inc. | -3.13 Million USD | 548.199% |
| Talis Biomedical Corporation | 371 Thousand USD | -3689.757% |
| Spectral AI, Inc. | 7.88 Million USD | -78.426% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 313.289% |
| CVRx, Inc. | 33.03 Million USD | 57.444% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -1801.218% |
| Bioventus Inc. | 328.19 Million USD | 95.716% |
| Venus Concept Inc. | 52.16 Million USD | 73.048% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 11.606% |
| LivaNova PLC | 771.25 Million USD | 98.177% |
| 908 Devices Inc. | 25.32 Million USD | 44.475% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 95.467% |
| Nemaura Medical Inc. | -1.47 Million USD | 1052.322% |
| NeuroPace, Inc. | 48.12 Million USD | 70.783% |
| LENSAR, Inc. | 21.1 Million USD | 33.387% |
| Apyx Medical Corporation | 14.12 Million USD | 0.439% |
| Cutera, Inc. | 41.49 Million USD | 66.116% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 23.839% |
| BioSig Technologies, Inc. | 18 Thousand USD | -78011.111% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 86.361% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -3.276% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 98.417% |
| Axonics, Inc. | 274.55 Million USD | 94.879% |
| Outset Medical, Inc. | 29 Million USD | 51.517% |
| IRIDEX Corporation | 21.8 Million USD | 35.525% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 80.211% |
| IRadimed Corporation | 50.15 Million USD | 71.969% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -4798.955% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1194.495% |
| Telesis Bio, Inc. | 16.95 Million USD | 17.05% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 87.534% |
| Varex Imaging Corporation | 256.9 Million USD | 94.527% |
| Quipt Home Medical Corp. | 163.84 Million USD | 91.419% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3563.054% |
| Pulmonx Corporation | 50.75 Million USD | 72.297% |
| Dynatronics Corporation | 7.63 Million USD | -84.152% |
| Modular Medical, Inc. | -768 Thousand USD | 1930.729% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -153.425% |
| Semler Scientific, Inc. | 61.2 Million USD | 77.026% |
| InMode Ltd. | 411.34 Million USD | 96.582% |
| Bruker Corporation | 1.51 Billion USD | 99.073% |
| Cytosorbents Corporation | 22.39 Million USD | 37.21% |
| DexCom, Inc. | 2.28 Billion USD | 99.386% |
| Align Technology, Inc. | 2.71 Billion USD | 99.483% |
| Viveve Medical, Inc. | 620 Thousand USD | -2167.742% |
| ZimVie Inc. | 290.38 Million USD | 95.158% |
| Movano Inc. | -158 Thousand USD | 8998.734% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 87.151% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -16429.509% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 96.176% |
| Profound Medical Corp. | 4.51 Million USD | -211.474% |
| Insulet Corporation | 1.15 Billion USD | 98.788% |
| enVVeno Medical Corporation | -546 Thousand USD | 2675.092% |
| Surmodics, Inc. | 93.05 Million USD | 84.89% |
| iCAD, Inc. | 14.53 Million USD | 3.275% |
| Nuwellis, Inc. | 4.98 Million USD | -182.159% |
| Biotricity, Inc. | 8.35 Million USD | -68.257% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 95.763% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 4015.813% |
| InspireMD, Inc. | 1.8 Million USD | -678.085% |
| PAVmed Inc. | -3.96 Million USD | 454.335% |
| BIOLASE, Inc. | 16.72 Million USD | 15.929% |
| Beyond Air, Inc. | -1.3 Million USD | 1175.746% |
| FONAR Corporation | 45.14 Million USD | 68.852% |
| AxoGen, Inc. | 127.87 Million USD | 89.005% |
| Vivani Medical, Inc. | -357 Thousand USD | 4038.375% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 92.795% |
| Inari Medical, Inc. | 434.56 Million USD | 96.765% |
| UFP Technologies, Inc. | 112.22 Million USD | 87.472% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -112209.29% |
| Tenon Medical, Inc. | 1.24 Million USD | -1032.957% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 17458.025% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -435.193% |
| AdaptHealth Corp. | 479.56 Million USD | 97.068% |
| Sintx Technologies, Inc. | 1.84 Million USD | -662.887% |
| NanoVibronix, Inc. | 1.53 Million USD | -814.769% |
| Quanterix Corporation | 70.64 Million USD | 80.098% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3563.054% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 73.361% |
| TransMedics Group, Inc. | 154.09 Million USD | 90.876% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -215.742% |
| NeuroMetrix, Inc. | 3.94 Million USD | -256.183% |
| Hyperfine, Inc. | 4.75 Million USD | -195.564% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 86.857% |
| Biomerica, Inc. | 611 Thousand USD | -2201.146% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 66.273% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1900.36% |
| Silk Road Medical, Inc | 127.08 Million USD | 88.937% |